CareView Communications Inc: An Investor’s "Cheat Sheet"

CareView provides healthcare technology for virtual patient observation. Their CareView System uses high-definition cameras, two-way audio, and specialized software for centralized monitoring. One observer can monitor up to 24 patients at once. This helps hospitals manage nursing shortages and prevents patient falls, which can cost hospitals over $30,000 per incident.

1. The Big Shift: How they make money

CareView is moving from a rental model to a sales-based model to speed up cash collection.

• The Change: Previously, CareView owned the hardware, which required heavy upfront spending. Now, hospitals buy the cameras and servers directly. CareView adds fees for installation, annual software licenses, and maintenance.
• Why it matters: This shifts the cost of equipment to the hospital. CareView now records revenue as soon as they ship and install the gear. This strategy is working: sales-based contracts hit $2.53 million in 2025, a 232% jump from 2024. This transition helps fund research without needing to issue more shares, which would dilute your ownership.

2. Financial Health: Turning the Corner?

The company is becoming more efficient, though its balance sheet remains tight.

• Revenue Growth: Total revenue reached $9.02 million in 2025, a 9.3% increase over 2024.
• Cutting Costs: Management cut operating expenses from $9.83 million to $9.07 million by reducing staff and streamlining their supply chain.
• The Bottom Line: The company’s loss narrowed to $3.2 million in 2025, down from $4.7 million in 2024. Most importantly, they generated $805,000 in cash from operations in 2025, a major improvement over the previous year’s cash burn.

3. The "Pre-Approved" Advantage

CareView has secured agreements with major industry groups like HealthTrust, Premier, and Vizient.

• Strategic Impact: These groups represent thousands of U.S. hospitals. Being pre-approved acts as a "fast-pass," allowing CareView to bypass long, individual sales processes. This lowers the cost of acquiring new customers and provides a clear path to grow across large hospital networks.

4. Risks: What to watch

• The "Going Concern" Warning: Auditors have warned that the company may struggle to stay in business. They face a $43.5 million deficit, largely due to debt coming due. Without more cash or a massive sales surge, they may struggle to pay their debts through 2026.
• Customer Concentration: One customer accounted for 14.9% of 2025 revenue. Losing this client would significantly hurt their cash flow.
• Micro-Cap Volatility: With few shares available and only about 800 shareholders, the stock price can swing wildly. Low trading volume means small trades can cause big price changes.

Bottom Line: CareView is successfully moving toward a cash-generating model. However, they remain in a fragile financial position. They are in a race to grow sales fast enough to pay off their $43.5 million debt before their cash runs out.

Investor Tip: Before considering an investment, check the company's next quarterly filing to see if their cash-from-operations trend remains positive and if they have made progress in paying down their debt obligations.